Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 17/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 16/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4735943 | 0.88 | HRH3 (0.79) | HRH3SLC6A4SLC6A2SMN1; SMN2KDM4E | |
| SCHEMBL4733844 | 0.87 | HRH3 (0.78) | HRH3SLC6A4SLC6A2SMN1; SMN2KDM4E | |
| SCHEMBL4920955 | 0.83 | HRH3 (0.74) | HRH3SLC6A4SLC6A2SMN1; SMN2KDM4E | |
| SCHEMBL4736356 | 0.83 | HRH3 (0.74) | HRH3SLC6A4SLC6A2 | |
| SCHEMBL4733850 | 0.80 | HRH3 (0.74) | HRH3SLC6A4SLC6A2 | |
| SCHEMBL4911688 | 0.80 | HRH3 (1.00) | HRH3SLC6A4SLC6A2 | |
| Trifluoroacetic Acid SCHEMBL4795585 | 0.79 | HRH3 (0.63) | HRH3SLC6A4SLC6A2SMN1; SMN2KDM4E | |
| Fumaric Acid SCHEMBL4920637 | 0.78 | SLC6A4 (0.85) | HRH3SLC6A4SLC6A2 | |
| Maleic Acid SCHEMBL4920633 | 0.78 | SLC6A4 (0.85) | HRH3SLC6A4SLC6A2 | |
| SCHEMBL4916086 | 0.78 | HRH3 (0.70) | HRH3SLC6A4SLC6A2SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080139564-A1 | SUBSTITUTED PHENYL PROPYL AMINES AS HISTAMINE H3 RECEPTOR AND SEROTONIN TRANSPORTER MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-12 | — | — | US | disclosed |
| WO-2008064036-A1 | SUBSTITUTED PHENYL PROPYL AMINES AS HISTAMINE H3 RECEPTOR AND SEROTONIN TRANSPORTER MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139564-A1 | SUBSTITUTED PHENYL PROPYL AMINES AS HISTAMINE H3 RECEPTOR AND SEROTONIN TRANSPORTER MODULATORS | HRH3, SLC6A4, HNMT | HRH3 1/4885SLC6A4 2/4885SLC6A2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.